Mydecine Innovations Group Inc. Patent Application Trends in 2024

From WikiPatents

Revision as of 03:19, 16 July 2024 by Wikipatents (talk | contribs) (Updating Mydecine Innovations Group Inc._Patent_Application_Trends_in_2024)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Contents

1 Mydecine Innovations Group Inc. Patent Filing Activity
2 Mydecine Innovations Group Inc. patent applications in 2024
3 Top 10 Technology Areas
4 Emerging Technology Areas
5 Top Inventors
6 Patent Categories
7 Geographical Distribution of Inventors
8 Geographical Distribution of US Inventors

Mydecine Innovations Group Inc. Patent Filing Activity

Mydecine Innovations Group Inc. patent applications in 2024

Top 10 Technology Areas

A61K45/06 (No explanation available)
- Count: 3 patents
- Example: 20240197679. NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS simplified abstract (Mydecine Innovations Group Inc.)
C07D209/14 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
C07D209/12 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
C07D209/16 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
C07D471/04 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
A61K31/39 (No explanation available)
- Count: 1 patents
- Example: 20240197679. NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS simplified abstract (Mydecine Innovations Group Inc.)
A61K31/381 (No explanation available)
- Count: 1 patents
- Example: 20240197679. NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS simplified abstract (Mydecine Innovations Group Inc.)
C07D317/58 (No explanation available)
- Count: 1 patents
- Example: 20240018117. PRODRUG COMPOUNDS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND METHODS OF SYNTHESIZING THE SAME simplified abstract (Mydecine Innovations Group Inc.)
C07D327/04 (No explanation available)
- Count: 1 patents
- Example: 20240018117. PRODRUG COMPOUNDS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND METHODS OF SYNTHESIZING THE SAME simplified abstract (Mydecine Innovations Group Inc.)
C07D277/62 (No explanation available)
- Count: 1 patents
- Example: 20240092747. SHORT-ACTING 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOGS INCORPORATING BENZOTHIAZOLE simplified abstract (Mydecine Innovations Group Inc.)

Emerging Technology Areas

C07D277/62 (No explanation available)
- Count: 1 patents
- Example: 20240092747. SHORT-ACTING 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ANALOGS INCORPORATING BENZOTHIAZOLE simplified abstract (Mydecine Innovations Group Inc.)
C07D327/04 (No explanation available)
- Count: 1 patents
- Example: 20240018117. PRODRUG COMPOUNDS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND METHODS OF SYNTHESIZING THE SAME simplified abstract (Mydecine Innovations Group Inc.)
C07D317/58 (No explanation available)
- Count: 1 patents
- Example: 20240018117. PRODRUG COMPOUNDS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND METHODS OF SYNTHESIZING THE SAME simplified abstract (Mydecine Innovations Group Inc.)
A61K31/381 (No explanation available)
- Count: 1 patents
- Example: 20240197679. NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS simplified abstract (Mydecine Innovations Group Inc.)
A61K31/39 (No explanation available)
- Count: 1 patents
- Example: 20240197679. NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS simplified abstract (Mydecine Innovations Group Inc.)
C07D471/04 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
C07D209/16 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
C07D209/12 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
C07D209/14 (No explanation available)
- Count: 2 patents
- Example: 20240101513. Novel Aza-Substituted Psilocin Analogs And Methods Of Synthesizing The Same simplified abstract (Mydecine Innovations Group Inc.)
A61K45/06 (No explanation available)
- Count: 3 patents
- Example: 20240197679. NOVEL SHORT-ACTING PSYCHOACTIVE COMPOUNDS OF THE MDMA CLASS simplified abstract (Mydecine Innovations Group Inc.)

Top Inventors

Denton W. Hoyer of West Haven CT (US) (5 patents)
Robert F. Roscow of Longmont CO (US) (5 patents)
Rong Ling (3 patents)
Chuanjun Gao (3 patents)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Retrieved from "http://wikipatents.org/index.php?title=Mydecine_Innovations_Group_Inc._Patent_Application_Trends_in_2024&oldid=103328"